Hind Hadid

Hind Hadid practices at Corewell Health Dearborn Hospital in Dearborn, Michigan, part of Corewell Health.

Hind Hadid's NPI, 1720427743, was assigned on June 24, 2013. Hind Hadid holds Michigan license 4301102891.

Hind Hadid's primary practice is Corewell Health Dearborn Hospital, at 18101 Oakwood Blvd, Dearborn, MI 48124 in Wayne County. The practice phone is (313) 593-7125.

Hind Hadid's primary practice is Corewell Health Dearborn Hospital in Dearborn, Michigan, part of Corewell Health. Hind Hadid is also affiliated with Corewell Health Wayne Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Hind Hadid to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hind Hadid practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Hind Hadid's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Hind Hadid is licensed in Michigan.

CMS data shows 460 Medicare services from Hind Hadid across 5 procedure codes in 2024, for 139 Medicare patients. Medicare paid $34,800 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Hind Hadid in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 3.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hind Hadid's median patient age at 59, with 52% women.

In 2024, Hind Hadid wrote 225 Medicare Part D claims for 74 patients. 76% of them were for generic drugs. CMS names the drug for 107 of them, across 7 drugs with 11 or more claims each, at $106,302 in total drug cost. In 2023, CMS named 104 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Hind Hadid for performance year 2024, reported as part of a group. Hind Hadid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Hind Hadid as offering telehealth.

Dmand AI links 1 paper to Hind Hadid in 2020. Hind Hadid's most frequent co-authors are Cecilia Big, MD, Vikisha Hazariwala, DO and Denise Kirsch, MD.

CMS Open Payments shows 3 general payments to Hind Hadid from 2 drug and device companies from 2017 to 2025. Education make up the largest share, 94% of the total. Astellas Pharma US Inc paid the most, $167.